MedPath

The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol

Not Applicable
Completed
Conditions
Seated Control
Walking
Interventions
Behavioral: Seated Control
Behavioral: Walking
Registration Number
NCT02834689
Lead Sponsor
University of British Columbia
Brief Summary

Walking is encouraged for people with type 2 diabetes but there is little evidence that performing a bout of walking can improve glucose control. Furthermore, it is unknown how participant characteristics (e.g., age, sex, medications) impact the acute glucose responses to walking in people with type 2 diabetes. The primary purpose of this study is to examine how a standardized bout of walking impacts glucose control assessed over 24 hours using continuous glucose monitoring. A secondary purpose is to determine whether responses are influenced by age, sex, and medication use.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
79
Inclusion Criteria
  • Diagnosed with T2D for more than 6 months
  • 30-90 years of age
  • No contra-indications to exercise (PAR-Q+, Rose Angina questionnaire, limited ability to walk for 50 min).
  • No previous myocardial infarction, stroke or diagnosed coronary artery disease
  • No changes in diabetes medication in last 3 months
  • Not treated by insulin or corticosteroids
  • No significant change in body weight (>5%) in last 3 months
  • Blood pressure <160/100 mmHg; resting HR<100
  • Able to understand English or French and comply with study requirements (e.g., attend visits during the day)
  • Hemoglobin A1C <9.0%
  • No prior history of hypoglycaemia during activity or sleep
Read More
Exclusion Criteria
  • Chest pain during physical activity.
  • Chest pain while resting (no physical activity) in the past month.
  • Loss of balance or consciousness because of dizziness in past 12 months
  • Bone or joint problem (for example, back, knee, or hip) that could be made worse by a change in physical activity.
  • Currently pregnant or planning on becoming pregnant in the next 3 months
  • Currently taking exogenous insulin
  • Previous heart attack or stroke
  • Any other reason that prevents ability to walk on a treadmill for 50 minutes
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Seated ControlSeated ControlSitting for 50 minutes
WalkingWalkingWalking on a treadmill at 3.5 metabolic equivalents (METS) for 50 minutes
Primary Outcome Measures
NameTimeMethod
Mean 24 hour glucose levels (mmol/l)24 hours

Mean glucose assessed for 24 hours after walking or seated control assessed by continuous glucose monitoring

Secondary Outcome Measures
NameTimeMethod
Mean amplitude of glycemic excursions (MAGE)24 hours

MAGE assessed for 24 hours after walking or seated control assessed by continuous glucose monitoring

Standard Deviation of Glucose Values24 hours

Standard deviation of glucose values assessed for 24 hours after walking or seated control assessed by continuous glucose monitoring

Post-dinner glucose control2 hours following dinner

Incremental area under the glucose curve for 2 hours following dinner

Post-lunch glucose control2 hours following lunch

Incremental area under the glucose curve for 2 hours following lunch

Post-breakfast glucose control2 hour following breakfast

Incremental area under the glucose curve for 2 hours following breakfast

Time spent above 10 mmol/l glucose24 hours following walking or seated control

Time in minutes above 10 mmol/l assessed by continuous glucose monitoring over 24 hours

Trial Locations

Locations (1)

University of British Columbia, Okanagan.

🇨🇦

Kelowna, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath